Duration of intralipid's suppressive effect on NK cell's functional activity

American Journal of Reproductive Immunology

Volumn 60, Issue 3, 2008, Pages 258-263

  Roussev, Roumen G ^a,d   Acacio, Brian ^b   Ng, Siu C ^a   Coulam, Carolyn B ^a,c  

^a Millenova Immunology Laboratories   (United States)

^b Acacio Fertility Center   (United States)

^c Rinehart Center for Reproductive Medicine   (United States)

^d NONE   (United States)

Author keywords

Intralipid; NK cell activity; Suppression

Indexed keywords

INTRALIPID;

ARTICLE; CELL ACTIVITY; CELL FUNCTION; CELL STRAIN K 562; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; FEMALE INFERTILITY; FLOW CYTOMETRY; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; TARGET CELL; TREATMENT DURATION;

ABORTION, HABITUAL; CYTOTOXICITY, IMMUNOLOGIC; FAT EMULSIONS, INTRAVENOUS; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION;

EID: 50149108604     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00621.x     Document Type: Article

References (42)

1. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M: Maternal age and fetal loss: Population based register linkage study. BMJ 2000; 320:1708.
2. Coulam CB, Stephenson M, Stern JJ, Clark DA: Immunotherapy for recurrent pregnancy loss: Analysis of results from clinical trials. Am J Reprod Immunol 1996; 35:352-359.
3. Stern JJ, Dorfmann A, Gutierrez-Najar AJ, Cirrello M, Coulam CB: Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril 1996; 65:250-253.
4. Cramer DW, Wise LA: The epidemiology of recurrent pregnancy loss. Semin reprod Med 2000; 18:331-339.
5. Tempelton A, Morris JK, Parslow W: Factors that affect outcome of in-vitro fertilization treatment. Lancet 1996; 348:1402-1406.
6. Clark DA: Immunology of pregnancy. In Medical Complications during Pregnancy, 6th edn, Burrow GN, Duffy T, Copel J (eds). Yale University, WB Saunders, 2004, pp 592.
7. Clark DA, Arck P, Chaoaut G: Why did your mother reject you? Immunolgenetic determinant of the response to environmental selective pressure expressed at the uterine level. Am J Reprod Immunol 1999; 41:5-22.
8. King A, Loke YW: On the nature and function of human uterine granular lymphocytes. Immunol Today 1991; 12:432-435.
9. Coulam CB, Goodman C, Roussev RG, Thomason EJ, Beaman KG: Systemic CD56+ cells can predict pregnancy outcome. Am J Reprod Immunol 1995; 33:40-46.
10. Aoki K, Kajijura S, Matsumoto Y, Okada S, Yaghami Y, Gleicher N: Preconceptual natural killer cells activation as a predictor of miscarriage. Lancet 1995; 135:1340-1342.
11. Kaider AS, Kaider BD, Janowicz PB, Roussev RG: Immunologic evaluation in women with reproductive failure. Am J Reprod Immunol 1999; 42:335-346.
12. Ntrivalas EI, Kwak-Kim JY, Gilman-Sachs A, Chung-Bang H, Ng SC, Beaman KD, Mantouvalos HP, Beer A: Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 2001; 16:855-861.
13. Kwak JYH, Beaman KD, Gilman-Sachs A, Ruiz JE, Schewitz D, Beer AE: Up-regulated expression of CD56+, CD56+/CD16+ and CD19+ cells in peripheral blood Lymphocytes in women with recurrent pregnancy losses. Am J Reprod Immunol 1995; 34:93-99.
14. Matsubayashi H, Hosaka T, Sugiama Y, Suzuki T, Arai T, Kondo A, Sugi T, Izumi S, Makino T: Increased natural killer-cell activity is associated with infertile women. Am J Reprod Immunol 2001; 46:318-322.
15. Coulam CB, Roussev RG: Correlation of NK cell activation and inhibition markers with NK cytotoxicity among women experiencing immunologic implantation failure after in vitro fertilization and embryo transfer. J Assist Reprod Genet 2003; 20:58-62.
16. Stricker RB, Steinleitner A, Winger EE: Intravenous immunoglobulin (IVIG) therapy for immunologic abortion. Clin Applied Immunol Rev 2002; 2:187-199.
17. Coulam CB, Krysa L, Stern JJ, Bustillo M: Intravenous immunoglobulin for treatment of in vitro fertilization failure. Hum Reprod 1994; 9:2265-2269.
18. Kwak JYH, Kwak FMY, Ainbinder SW, Ruiz AM, Beer A: Elevated peripheral blood natural killer cells are effectively suppressed by immunoglobulin G infusions in women with recurrent spontaneous abortions. Am J Reprod Immunol 1996; 35:363-369.
19. Clark DA, Coulam CB, Stricker RB: Is IVIg efficacious in early pregnancy failure? J Assis Reprod Genet 2006; 23:1-13.
20. Roussev RG, Ng Sc, Coulam CB: Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G. Am J Reprod Immunol 2007; 57:262-269.
21. Kane KL, Ashton FA, Schmitz JL, Folds JD: Determinations of natural killer cell function by flow cytometry. Clin Diag Lab Immunol 1996; 3:295-300.
22. Lachapelle MH, Miron P, Hemmings R, Roy DC: Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. J Immunol 1996; 156:4027-4034.
23. Haddad EK, Duclos AJ, Lapp WS, Baines MG: Early embryo loss is associated with the prior expression of macrophage activation markers in the deciduas. J Immunol 1997; 158:4886.
24. Granato D, Blum S, Rossle C, Le Boucher J, Malnos A, Dutot G: Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro. J Parenter Enterak Nutr 2000; 24:113-118.
25. Mayer K, Meyer S, Reinholz-Muhly M, Maus U, Merfels M, Lohmeyer J, Grimminger F, Seeger W: Short-time infusion of fish-oil based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive iomteraction with endothelium in humans. J Immunol 2003; 171:4837-4843.
26. Krog J, Hoklland M, Ahlburg P, Parner E, Tonnesen E: Lipid solubility and concentration dependent attenuation of in vitro natural killer cell cytotoxicity by local anesthetics. Acta Anaesthesiol Scand 2002; 46:875-881.
27. Inoue H, Miyaji M, Kosugi A, Nagafukku M, Okazaki T, Mimori T, Amakawa R, Fukuhara S, Domae N, Bloom ET, Umehara H: Lipid rafts as the signaling scaffold for NK cell activation: Tyrosine phosphorylation and association of LAT with phosphotidlyinositol 3-kinase and phospholipase C-gamma following CD2 stimulation. Eur J Immunol 2002; 32:2188-2198.
28. Battistella FD, Widergren JT, Anderson JT, Siepler JK, Weber JC, MacColl K: A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition. J Trauma 1997; 43:52-58.
29. Sedman PC, Somers SS, Ramsden CW, Brennan TG, Guillou PJ: Effects of different lipid emulsions on lymphocyte function during total parenteral nutrition. Br J Surg 1991; 78:1396-1399.
30. Tezuka H, Sawada H, Sakoda H, Itoh K, Nishikori M, Amagai T, Uchino H, Mori KJ: Suppression of genetic resistance to bone marrow grafts and natural killer activity by administration of fat emulsion. Exp Hematol 1988; 12:609-612.
31. Clark DA: Intralipid as a treatment for recurrent unexplained abortion? Am J Reprod Immunol 1994; 32:290-293.
32. Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA: Natural killer cell receptors: New biology and insights into the graft-versus-host effect. Blood 2002; 100:1935-1947.
33. Zhang X, Rodriguez-Galan MC, Subleski JJ, Ortaldo JR, Hodge DL, Wang JM, Shimozato O, Reynolds DA, Young HA: Peroxisome proliferator-activated receptor-γ and its ligands attenuate biologic functions of human natural killer cells. Blood 2004; 104:3276-3284.
34. Versleijen M, Roelofs H, Preijers F, Roos D, Wanten G: Parenteral lipids modulate leukocytes phenotypes in whole blood, depending on their fatty acid composition. Clin Nutr 2005; 24:822-829.
35. Rodriguez JM, Ariaz-Diaz J, Figueredo MA, Torres-Molero J, Garcia-Carreras C, Gomez de la Concha E, Balibrea JL: Lymphocyte subpopulation and surgery. The role of postoperative parental nutrition. Nutr Hosp 1994; 9:324-330.
36. Desvergne B, Wahli W: Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrin Rev 1999; 20:649-688.
37. Khan SA, Vanden-Heuvel JP: Role of nuclear receptors in the regulation of gene expression by dietary fatty acids (review). J Nutr Biochem 2003; 14:554-567.
38. Delerove P, Fruchart JC, Staels B: Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 2001; 169:453-459.
39. Clark RB: The role of PPARs in inflammation and immunity. J Leukoc Biol 2002; 71:388-400.
40. Daynes RA, Jones DC: Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2002; 2:748-759.
41. Akiyama TE, Sakai G, Lambert G, Nicol CJ, Matsusue K, Pimprale S, Lee YH, Ricote M, Glass CK, Brewer HB Jr, Gonzalez FJ: Conditional disruption of the peroxisome proliferator-activator γ gene in mice results in lowered expression of ABCA1, ABCG1 and apoE in macrophages and reduced cholesterol efflux. Mol Cell Biol 2002; 22:2607-2619.
42. Koutnikova H, Cock TA, Watanabe M, Houten SM, Champy MF, Dierich A, Auwerx J. Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPARγ hypomorphic mice. Proc Nat Acad Sci USA 2003; 24:14457-14462.